Clinical trials: Lymph Node Neoplasm
Melanoma
Gene Expression Profiles and ctDNA for Risk Stratification in Patients With Melanoma
This study aims at assessing the role of MerlinTM and ctDNA in predicting the nodal status in patients with >pT3b melanoma, therefore candidate for adjuvant therapy regardless of sentinel lymph node status.
- Trial name
- CORRESPOND (NCT06566404)
- Volunteers
- 200 people
- Sponsor
- European Institute of Oncology
Head and Neck Cancer (H&Amp;Amp;N), Lymph Nodes
The eValuation of Sources of vIBRAtioN for Vibrational Shear Wave elasTography
Patients suffering with Head and Neck Cancer often must wait 3 months or more to know if their treatment has been effective, which can be very stressful.
- Trial name
- VIBRANT (NCT07098819)
- Testing
- Vibrational Shear wave elastography algorithm
- Volunteers
- 15 people, healthy volunteers welcome
- Sponsor
- Institute of Cancer Research, United Kingdom
Breast Cancer Female, Node-positive Breast Cancer
Axillary Staging in Node Positive Breast Cancer Patients Receiving PST. SNB vs PET/MRI
The management of axillary nodes in breast cancer patients is a highly debated and evolving field. To date, an increasing number of patients with positive lymph nodes receives primary systemic therapy (PST) prior to surgery…
- Conditions
- Breast Cancer Female, Node-positive Breast Cancer, Sentinel Lymph Node
- Trial name
- NCT04826211
- Testing
- PET/MRI
- Where
- Italy
- Volunteers
- 109 people
- Sponsor
- IRCCS San Raffaele
Stomach Neoplasms, Gastric Cancer (Diagnosis)
Lymph Node Metastasis Pattern After Neoadjuvant Chemoimmunotherapy in LAGC
The purpose of this observational study is to learn how stomach cancer that has spread to nearby lymph nodes responds to standard chemotherapy combined with immunotherapy given before surgery.
- Conditions
- Stomach Neoplasms, Gastric Cancer (Diagnosis), Gastric Adenocarcinoma
- Trial name
- NCT07899775
- Testing
- Neoadjuvant SOX chemotherapy combined with PD-1 inhibitor
- Volunteers
- 103 people
- Sponsor
- Hainan General Hospital
Colorectal Cancer, Lymph Node Metastasis
Study on the No.253 Lymph Node Metastasis Patterns in Left-Sided Colon and Rectal Cancer
The goal of this observational study is to learn about the the pattern of metastasis of the No.253 lymph node in colorectal cancer. The main questions it aims to answer are: 1.
- Trial name
- NCT06135571
- Testing
- Laparoscopic colorectal surgery
- Where
- 4 sites in China
- Volunteers
- 3,000 people
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Siewert Type II/III Gastroesophageal Junction Adenocarcinoma
Safety and Short-term Outcomes of Modular Robotic System for Siewert II/III Gastroesophageal Junction Cancer
Siewert type II/III gastroesophageal junction (GEJ) adenocarcinoma is a challenging malignancy located at the anatomical transition between the esophagus and stomach.
- Trial name
- ROBOT-GEJ (NCT07790809)
- Testing
- Robotic-assisted radical resection for Siewert type II/III gastroesophageal junction cancer
- Where
- China
- Volunteers
- 25 people
- Sponsor
- The First Hospital of Jilin University
Vulvar Cancer, Sentinel Lymph Node
Optical Guided Sentinel Node Biopsy for Staging of Vulvar Cancer (I)
The aim of this study is to investigate whether Sentinel Node biopsy can be performed without the use of lymphoscintigraphy and with ICG as a mono-tracer in women with vulvar cancer, unifocal tumor < 4 cm (clinical stage IB and…
- Trial name
- SENTIVUC (NCT06029504)
- Where
- Denmark
- Volunteers
- 115 people
- Sponsor
- Copenhagen University Hospital, Rigshospitalet
Submucosal Tumor of Gastrointestinal Tract
Diagnostic Accuracy of SurePath™ in EUS-FNA
It is a prospective randomized controlled study to evaluate the diagnostic accuracy of SurePath™ liquid-based cytology in endoscopic ultrasound-guided sampling.
- Trial name
- NCT05394129
- Testing
- SurePath™
- Where
- South Korea
- Volunteers
- 89 people
- Sponsor
- Seoul National University Hospital
Breast Carcinoma, Head and Neck Cancer
Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery
This is a single-center prospective clinical trial to evaluate non-inferiority of indocyanine green guided sentinel lymph node biopsy compared with the gold standard Technecium99 guided sentinel lymph node biopsy in patients with…
- Conditions
- Breast Carcinoma, Head and Neck Cancer, Melanoma (Skin), Squamous Cell Carcinoma, Skin
- Trial name
- GASVERT (NCT02997553)
- Testing
- Indocyanine green, Technetium99, Optonuclear probe
- Where
- France
- Volunteers
- 744 people
- Sponsor
- Institut de Cancérologie de Lorraine
Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms
The Diagnostic Value of PET/MRI in Head and Neck Cancer
This study investigates the diagnostic value of PET/MRI for cervical lymph node metastases from head and neck squamous cell carcinomas.
- Conditions
- Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Lymph Node Metastases
- Trial name
- NCT04117139
- Testing
- PET/MRI
- Where
- Denmark
- Volunteers
- 142 people
- Sponsor
- Odense University Hospital
Endometrial Cancer
Lymph Node Mapping in Patients With Endometrial Cancer
This clinical trial studies lymph node mapping in patients with endometrial cancer. Lymph node mapping may allow for limited removal of lymph nodes in as part of endometrial cancer staging and treatment.
- Trial name
- NCT01818739
- Testing
- sentinel lymph node detection, indocyanine green solution, isosulfan blue
- Where
- 2 sites in United States
- Volunteers
- 204 people
- Sponsor
- Ohio State University Comprehensive Cancer Center
Melanoma
Exploring an Alternative Pre-operative SLN Mapping Method Using a Magnetic Tracer and MRI for Melanoma Patients
Sentinel lymph node biopsy (SLNB) is crucial in the management of malignant melanoma treatment and is currently performed by pre-operatively inject a colloid nanomaterial labeled with Technetium (99mTc) as radioactive tracer.
- Trial name
- SCARLETT (NCT05145829)
- Testing
- Diagnostic Test: Sentinel node mapping using MRI
- Where
- Netherlands
- Volunteers
- 40 people
- Sponsor
- Zuyderland Medisch Centrum
Recurent Vulvar Carcinoma
International Prospective Multicentre Study That Evaluate the Sentinel Lymph Node Detection Rate in Patients With First Local Recurrent Scamous Cell Carcinoma of the Vulva.
Acronym: VULCA-NODE Study Title: Sentinel Node Biopsy in Relapsed Vulvar Cancer Primary Objetive: To evaluate the SLN detection rate in the first recurrent vulvar carcinoma setting.
- Trial name
- VULCA-NODE (NCT07023601)
- Testing
- Sentinel Lymph Node Biopsy in first local recurrent vulvar carcinoma
- Where
- Spain
- Volunteers
- 100 people
- Sponsor
- Hospital Universitario La Paz
HER2-positive Breast Cancer
Chemotherapy Combined With Targeted Therapy for High-risk HER2 Positive and Lymph Node Negative Early Breast Cancer
Human epidermal growth factor receptor 2 (HER2) positive breast cancer is a molecular subtype with high malignancy and easy recurrence and metastasis.
- Trial name
- TaxCbHER2 (NCT06722612)
- Where
- China
- Volunteers
- 2,916 people
- Sponsor
- Shu Wang
Non Palpable Cervical Lesions Suspicious for Metastasis
Ultrasound-Guided Hook-Wire Localization for Excision of Non-palpable Cervical Lesions Suspicious for Metastasis
The goal of this randomized controlled trial is to determine whether ultrasound-guided hook-wire localization improves surgical efficiency and accuracy compared with ultrasound-guided surgery alone for the excision of…
- Trial name
- NCT07672912
- Testing
- Ultrasound-guided hook-wire localization, Ultrasound-guided surgical excision alone
- Where
- Sweden
- Volunteers
- 50 people
- Sponsor
- Rusana Bark
Lymph Node Dissection, Lymphoedema
A Study for Lymphocele and Lymphorrhea Control Following Inguinal and Axillary Radical Lymph Node Dissection
Patients undergoing groin or axillary Radical lymph node dissection (RLND) or completion lymph node dissection (CLND, after positive sentinel lymph node biopsy (SLNB) for melanoma or breast cancer were randomized in a controlled…
- Conditions
- Lymph Node Dissection, Lymphoedema, Lymphocoele
- Trial name
- NCT02476357
- Testing
- Harmonic scalpel
- Where
- Switzerland
- Volunteers
- 80 people
- Sponsor
- University of Lausanne Hospitals
T1 Gastric Cancer Lymph Node Metastasis Early Gastric Cancer Artificial Intelligence-Assisted Diagnosis Multimodal Data Integration
Multimodal Deep Learning for Lymph Node Metastasis Prediction and Physician Performance Assessment in T1 Gastric Cancer
This study aims to develop and validate an artificial intelligence (AI) model that integrates clinical, pathological, and imaging data to predict the presence of lymph node metastasis (LNM) in patients with T1-stage gastric…
- Trial name
- NCT07124754
- Testing
- Multimodal Artificial Intelligence Diagnostic Model for Lymph Node Metastasis in T1 Gastric Cancer
- Where
- China
- Volunteers
- 300 people
- Sponsor
- Qun Zhao
Node-positive Breast Cancer
Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer (TAXIS)
RATIONALE: The use of tailored axillary dissection as a tailored procedure will avoid surgical overtreatment by selectively removing the lymph nodes that are affected by the cancer, thereby sparing many women the unnecessary…
- Trial name
- TAXIS (NCT03513614)
- Testing
- Tailored axillary surgery - both Arms, Radiotherapy - Arm A, Radiotherapy - Arm B
- Where
- 64 sites in United States, Argentina and 11 more
- Volunteers
- 1,500 people
- Sponsor
- University Hospital, Basel, Switzerland
Pancreatic Cyst, Pancreatic Neoplasms
Clinical Evaluation Of Needle-based Confocal Laser Endomicroscopy in The Lymph Nodes Along With Masses and Cystic Tumors of the Pancreas
This study focuses on three different lesions: pancreatic cysts, lymph nodes near the gastrointestinal tract and pancreatic masses.
- Conditions
- Pancreatic Cyst, Pancreatic Neoplasms, Pancreatic Adenoma, Pancreatic Cancer
- Trial name
- CONTACT (NCT01563133)
- Testing
- EUS-FNA, nCLE
- Where
- 3 sites in France
- Volunteers
- 330 people
- Sponsor
- Mauna Kea Technologies
Breast Cancer
Sentinel Node Biopsy in Breast Cancner: Omission of Axillary Clearance After Micrometastasis
Sentinel node (SN) biopsy in breast cancer has been demonstrated to be a reliable method, and several follow-up studies have shown that it is safe to refrain from completion axillary clearance (axillary lymph node dissection…
- Trial name
- SENOMIC (NCT02049632)
- Testing
- Omission of axillary clearance
- Where
- 22 sites in Sweden
- Volunteers
- 805 people
- Sponsor
- Karolinska Institutet
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.